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Background
The increasing frequency of C. difficile infections and the
increased frequency of relapses imposed implementation
of new treatment alternatives.
Methods
Starting with July 2013, in the National Institute for
Infectious Diseases “Prof. Dr. Matei Balş” we performed
32 therapies in patients with relapsing infections trough
bacterial re-colonization.
Results
We used as donors blood relatives (children, grand-
children) in 68.8% and in 31.2% cases we used stools
from others. The success rate at 90 days was 96.8%.
This success rate was achieved with a single procedure
in 74.1% of cases, with two procedures in 22.5% and in
3.2% of cases with three procedures. The success rate
was significantly higher in the first group.
Conclusion
Although the success of this maneuver is significantly
higher than the standard antibiotic treatment, there is
need to deepen the experience before generalizing it.
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